Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v3-EN | Version v1-EN | |
|---|---|---|
| Language | English | English |
| Date Updated | 2025-02-28 | 2024-09-27 |
| Drug Identification Number | 02220288 | 02220288 |
| Brand name | PENICILLIN G SODIUM FOR INJECTION, USP | PENICILLIN G SODIUM FOR INJECTION, USP |
| Common or Proper name | PENICILLIN G SODIUM FOR INJECTION, USP | PENICILLIN G SODIUM FOR INJECTION, USP |
| Company Name | FRESENIUS KABI CANADA LTD | FRESENIUS KABI CANADA LTD |
| Ingredients | PENICILLIN G | PENICILLIN G |
| Strength(s) | 5000000UNIT | 5000000UNIT |
| Dosage form(s) | POWDER FOR SOLUTION | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
| Packaging sizes (GTIN) | (See additional packaging sizes) | (See additional packaging sizes) |
| Additional packaging sizes | 15 mL | 15 mL |
| ATC code | J01CE | J01CE |
| ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | ||
| Actual start date | 2024-08-02 | 2024-08-02 |
| Estimated end date | 2025-01-31 | 2025-01-31 |
| Actual end date | 2025-01-31 | |
| Shortage status | Resolved | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | Fresenius Kabi Canada regrets to advise that due to further production delays, we will be extending the backorder on our Penicillin G Sodium for Injection, USP 5 million units SD Vial 15 mL until January 31, 2025. During this time, our Penicillin G Sodium for Injection, USP 10 million units SD Vial 50 mL will remain available as a substitute. | Fresenius Kabi Canada regrets to advise that due to further production delays, we will be extending the backorder on our Penicillin G Sodium for Injection, USP 5 million units SD Vial 15 mL until January 31, 2025. During this time, our Penicillin G Sodium for Injection, USP 10 million units SD Vial 50 mL will remain available as a substitute. |
| Health Canada comments |